These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2172395)

  • 1. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.
    Farr BM; Gwaltney JM; Hendley JO; Hayden FG; Naclerio RM; McBride T; Doyle WJ; Sorrentino JV; Riker DK; Proud D
    J Infect Dis; 1990 Nov; 162(5):1173-7. PubMed ID: 2172395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral prednisone therapy in experimental rhinovirus infections.
    Gustafson LM; Proud D; Hendley JO; Hayden FG; Gwaltney JM
    J Allergy Clin Immunol; 1996 Apr; 97(4):1009-14. PubMed ID: 8655877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
    Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
    JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
    Pitkäranta A; Wecker MT; Korts DC; Hayden FG
    Am J Rhinol; 1998; 12(2):125-9. PubMed ID: 9578931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.
    Proud D; Gwaltney JM; Hendley JO; Dinarello CA; Gillis S; Schleimer RP
    J Infect Dis; 1994 May; 169(5):1007-13. PubMed ID: 8169385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinins are generated in nasal secretions during natural rhinovirus colds.
    Proud D; Naclerio RM; Gwaltney JM; Hendley JO
    J Infect Dis; 1990 Jan; 161(1):120-3. PubMed ID: 2295843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM; Gwaltney JM; Adams KF; Hayden FG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
    Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of experimental rhinovirus colds by receptor blockade.
    Hayden FG; Gwaltney JM; Colonno RJ
    Antiviral Res; 1988 Jul; 9(4):233-47. PubMed ID: 2849376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interferon-gamma as prophylaxis against rhinovirus colds in volunteers.
    Higgins PG; al-Nakib W; Barrow GI; Tyrrell DA
    J Interferon Res; 1988 Oct; 8(5):591-6. PubMed ID: 2853194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds.
    Gaffey MJ; Gwaltney JM; Dressler WE; Sorrentino JV; Hayden FG
    Am Rev Respir Dis; 1987 Jan; 135(1):241-4. PubMed ID: 3800150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
    Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
    J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on the nasal mucosa of upper respiratory viruses (common cold).
    Winther B
    Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial.
    Abisheganaden JA; Avila PC; Kishiyama JL; Liu J; Yagi S; Schnurr D; Boushey HA
    Am J Med; 2000 Apr; 108(6):453-9. PubMed ID: 10781777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.
    Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB
    Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
    Sperber SJ; Sorrentino JV; Riker DK; Hayden FG
    Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds.
    Doyle WJ; Riker DK; McBride TP; Hayden FG; Hendley JO; Swarts JD; Gwaltney JM
    Ann Otol Rhinol Laryngol; 1993 Jul; 102(7):521-7. PubMed ID: 8392820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.